Two FDA-Approved Cancer Drugs Show Promise in Reversing Alzheimer's Effects
TL;DR Summary
Researchers have discovered that two FDA-approved cancer drugs, letrozole and irinotecan, can reduce tau protein clumps and improve cognitive functions in mice, offering a promising new approach for Alzheimer's treatment through drug repurposing. Further studies are needed to confirm their effectiveness in humans.
- Alzheimer’s Could Be Treated with These Two FDA-Approved Cancer Drugs, New Research Finds Indian Defence Review
- Scientists Find 2 Existing Drugs Can Reverse Alzheimer's Brain Damage in Mice ScienceAlert
- Do These Two Cancer Drugs Have What It Takes to Beat Alzheimer’s? UC San Francisco
- Two cancer drugs show promise in reversing Alzheimer's devastating effects Fox News
- Cancer Drugs for Alzheimer's? Gene Therapy Distribution Halted; Reframing APOE4 MedPage Today
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 3 min read
Condensed
92%
569 → 43 words
Want the full story? Read the original article
Read on Indian Defence Review